Showing 1 - 20 results of 44 for search '"ЭНДОСКОПИЧЕСКОЕ ЛИГИРОВАНИЕ"', query time: 1.05s Refine Results
  1. 1
    Academic Journal

    Source: Russian Journal of Transplantology and Artificial Organs; Том 26, № 1 (2024); 36-46 ; Вестник трансплантологии и искусственных органов; Том 26, № 1 (2024); 36-46 ; 1995-1191

    File Description: application/pdf

    Relation: https://journal.transpl.ru/vtio/article/view/1742/1561; https://journal.transpl.ru/vtio/article/view/1742/1625; https://journal.transpl.ru/vtio/article/downloadSuppFile/1742/1528; https://journal.transpl.ru/vtio/article/downloadSuppFile/1742/1529; https://journal.transpl.ru/vtio/article/downloadSuppFile/1742/1530; https://journal.transpl.ru/vtio/article/downloadSuppFile/1742/1531; https://journal.transpl.ru/vtio/article/downloadSuppFile/1742/1532; https://journal.transpl.ru/vtio/article/downloadSuppFile/1742/1533; D’Amico G, Bernardi M, Angeli P. Towards a new definition of decompensated cirrhosis. J Hepatol. 2022; 76 (1): 202–207. doi.org/:10.1016/j.jhep.2021.06.018.; D’Amico G, Perricone G. Prediction of Decompensation in Patients with Compensated Cirrhosis: Does Etiology Matter? Curr Hepatology Rep. 2019; 18: 144–156. doi.org/10.1007/s11901-019-00473-1.; De Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VII Faculty. Baveno VII – Renewing consensus in portal hypertension. J Hepatol. 2022; 76 (4): 959–974. doi.org/10.1016/j.jhep.2021.12.022.; Kwong AJ, Ebel NH, Kim WR, Lake JR, Smith JM, Schladt DP et al. OPTN/SRTR 2020 Annual Data Report: Liver. Am J Transplant. 2022 Mar; 22 Suppl 2: 204–309. doi:10.1111/ajt.16978.; Toniutto P, Zanetto A, Ferrarese A, Burra P. Current challenges and future directions for liver transplantation. Liver Int. 2017; 37 (3): 317–327. doi.org/:10.1111/liv.13255.; Gautier SV, Khomyakov SM. Organ donation and transplantation in the Russian Federation in 2021. 14th Report from the Registry of the Russian Transplant Society. Russian Journal of Transplantology and Artificial Organs. 2022; 24 (3): 8–31. doi.org/10.15825/1995-11912022-3-8-31.; Коробка ВЛ, Пасечников ВД, Коробка РВ, Пак ЕС, Шаповалов АМ. Использование эндоскопического лигирования варикозных узлов в комбинации с неселективными β-блокаторами, или самостоятельно, в профилактике кровотечений у больных с асцитом, включенных в лист ожидания трансплантации печени. Вестник трансплантологии и искусственных органов. 2022; 24 (3): 42–50. doi.org/10.15825/1995-1191-2022-3-42-50.; D’Amico G, Pasta L, Morabito A, D’Amico M, Caltagirone M, Malizia G et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther. 2014 May; 39 (10): 1180–1193. doi:10.1111/apt.12721.; Balcar L, Tonon M, Semmler G, Calvino V, Hartl L, Incicco S et al. Baveno Cooperation: an EASL consortium. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event. JHEP Rep. 2022 Jun 3; 4 (8): 100513. doi:10.1016/j.jhepr.2022.100513.; Cárdenas A, Ginès P, Uriz J, Bessa X, Salmerón JM, Mas A et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology. 2001 Oct; 34 (4 Pt 1): 671–676. doi:10.1053/jhep.2001.27830. PMID: 11584362.; Fasolato S, Angeli P, Dallagnese L, Maresio G, Zola E, Mazza E et al. Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology. 2007 Jan; 45 (1): 223–229. doi:10.1002/hep.21443.; Planas R, Montoliu S, Ballesté B, Rivera M, Miquel M, Masnou H et al. Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol. 2006 Nov; 4 (11): 1385–1394. doi:10.1016/j.cgh.2006.08.007.; Jepsen P, Ott P, Andersen PK, Sørensen HT, Vilstrup H. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology. 2010 May; 51 (5): 1675–1682. doi:10.1002/hep.23500. PMID:20186844.; De Franchis R. Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015; 63: 743–752. doi.org/10.1016/j.jhep.2015.05.022.; Варикозное расширение вен пищевода. Практические рекомендации Всемирной гастроэнтерологической организации. Available at: https://www.worldgastroenterology.org/UserFiles/file/guidelines/esophageal-varices-russian-2014.pdf.; Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003; 38 (1): 258–266. doi.org/10.1053/jhep.2003.50315.; Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int. 2012; 2 (Suppl.): 1–138.; Angeli P, Gines P, Wong F, Bernardi M, Boyer TD, Gerbes A et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites [published corrections appears in J Hepatol. 2015; 63: 290. doi.org/10.1016/j.hep.2015.04.001]. J Hepatol. 2015; 62 (4): 968–974. doi.org/10.1016/j.jhep.2014.12.029.; DeMers D, Wachs D. Physiology, Mean Arterial Pressure. [Updated 2023 Apr 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538226/.; Хубутия МШ, Восканян СЭ, Сюткин ВЕ, Чуланов ВП, Новрузбеков МС, Пасечников ВД и др. Рекомендации по профилактике и лечению инфекций вирусами гепатита В и С у больных, находящихся в листе ожидания трансплантации печени, и реципиентов печени. Трансплантология. 2020; 12 (3): 231–244. doi.org/10.23873/2074-0506-2020-12-3-231-244.; Singh V, Kumar P, Verma N, Vijayvergiya R, Singh A, Bhalla A. Propranolol vs. band ligation for primary prophylaxis of variceal hemorrhage in cirrhotic patients with ascites: a randomized controlled trial. Hepatol Int. 2022 Aug; 16 (4): 944–953. doi:10.1007/s12072-02210361-4.; Scheiner B, Parada-Rodriguez D, Bucsics T, Schwabl P, Mandorfer M, Pfisterer N et al. Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varices. Scand J Gastroenterol. 2017 Sep; 52 (9): 1008–1015. doi:10.1080/00365521.2017.1329456.; Коробка ВЛ, Пасечников ВД, Коробка РВ, Пак ЕС, Шаповалов АМ, Пасечников ДВ, Шитиков ИВ. Сравнение эффективности неселективных бета-блокаторов и эндоскопического лигирования варикозных вен пищевода в первичной профилактике кровотечений у больных с асцитом, включенных в лист ожидания трансплантации печени. Медицинский вестник Северного Кавказа. 2023; 18 (1): 14–20. doi.org/10.14300/mnnc.2023.18004.; Pérez-Ayuso RM, Valderrama S, Espinoza M, Rollán A, Sánchez R, Otarola F et al. Endoscopic band ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhotic patients with high-risk esophageal varices. Ann Hepatol. 2010 Jan-Mar; 9 (1): 15–22.; Wei ZG, Wei FX, Shao ZW, Su GH, Qi XP, Zhang YC. Lowering hepatic venous pressure agent carvedilol versus variceal banding ligation for clinical outcomes of cirrhotic portal hypertension. Ther Clin Risk Manag. 2018 Dec 24; 15: 45–57. doi:10.2147/TCRM.S184863.; Pfisterer N, Dexheimer C, Fuchs EM, Bucsics T, Schwabl P, Mandorfer M et al. Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding. Aliment Pharmacol Ther. 2018 Apr; 47 (7): 966–979. doi:10.1111/apt.14485.; Lai M, Fenton C, Ge J, Rubin J, Lai JC, Cullaro G. Nonselective beta-blockers may lead to stage 2 acute kidney injury and waitlist mortality in child class C cirrhosis. Hepatol Commun. 2023 Sep 27; 7 (10): e0255. doi:10.1097/HC9.0000000000000255.; Sersté T, Njimi H, Degré D, Deltenre P, Schreiber J, Lepida A et al. The use of beta-blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis. Liver Int. 2015 Aug; 35 (8): 1974–1982. doi:10.1111/liv.12786. Epub 2015 Feb 4. PMID: 25611961.; Ngwa T, Orman E, Gomez EV, Vuppalanchi R, Kubal C, Chalasani N, Ghabril M. Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation. BMC Gastroenterol. 2020 Jan 6; 20 (1): 4. doi:10.1186/s12876-019-1155-1.; https://journal.transpl.ru/vtio/article/view/1742

  2. 2
    Academic Journal

    Source: Russian Journal of Transplantology and Artificial Organs; Том 26, № 2 (2024); 34-41 ; Вестник трансплантологии и искусственных органов; Том 26, № 2 (2024); 34-41 ; 1995-1191

    File Description: application/pdf

    Relation: https://journal.transpl.ru/vtio/article/view/1798/1604; https://journal.transpl.ru/vtio/article/view/1798/1646; https://journal.transpl.ru/vtio/article/downloadSuppFile/1798/1627; https://journal.transpl.ru/vtio/article/downloadSuppFile/1798/1628; https://journal.transpl.ru/vtio/article/downloadSuppFile/1798/1629; https://journal.transpl.ru/vtio/article/downloadSuppFile/1798/1630; https://journal.transpl.ru/vtio/article/downloadSuppFile/1798/1631; https://journal.transpl.ru/vtio/article/downloadSuppFile/1798/1632; De Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C; Baveno VII Faculty. Baveno VII – Renewing consensus in portal hypertension. J Hepatol. 2022; 76 (4): 959–974. PMID: 35120736. doi:10.1016/j.jhep.2021.12.022.; Liu L, Nie Y, Liu Q, Zhu X. A Practical Model for Predicting Esophageal Variceal Rebleeding in Patients with Hepatitis B-Associated Cirrhosis. Int J Clin Pract. 2023 Aug 3; 2023: 9701841. doi:10.1155/2023/9701841.; Коробка ВЛ, Пак ЕС, Шаповалов АМ, Кострыкин МЮ, Ткачев АВ. Оценка четырехлетнего ведения листа ожидания трансплантации печени Ростовской области: перспективы снижения смертности в листе. Медицинский вестник Юга России. 2019; 10 (3): 32–39. doi:10.21886/2219-8075-2019-10-3-32-39.; Garcia-Tsao G, Bosch J. Varices and Variceal Hemorrhage in Cirrhosis: A New View of an Old Problem. Clin Gastroenterol Hepatol. 2015; 13: 2109–2117. doi:10.1016/j.cgh.2015.07.012.; Asghar S, Mustafa J, Rehman HU, Farooq MK, Waheed MU, Shahid S. Predictors Of Re-Bleeding After Oesophageal Variceal Banding In Cirrhotic Patients At 4 Weeks. J Ayub Med Coll Abbottabad. 2023 Feb-Mar; 35 (1): 99–103. PMID: 36849386.; Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017; 65: 310–335. doi:10.1002/hep.28906.; Lv Y, Qi X, He C, Wang Z, Yin Z, Niu J et al. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial. Gut. 2018 Dec; 67 (12): 2156–2168. doi:10.1136/gutjnl-2017-314634.; Bucsics T, Schoder M, Goeschl N, Schwabl P, Mandorfer M, Diermayr M et al. Rebleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice. Dig Liver Dis. 2017 Dec; 49 (12): 1360–1367. doi:10.1016/j.dld.2017.08.002.; Bodzin AS, Baker TB. Liver Transplantation Today: Where We Are Now and Where We Are Going. Liver Transpl. 2018 Oct; 24 (10): 1470–1475. doi:10.1002/lt.25320.; Назыров ФГ, Девятов АВ, Бабаджанов АХ, Салимов УР. Эволюция технологий азигопортального разобщения в профилактике кровотечений портального генеза. Анналы хирургической гепатологии. 2018; 23 (1): 65–73. doi:10.16931/1995-5464.2018165-73.; Коробка ВЛ, Шаповалов АМ, Данильчук ОЯ, Коробка РВ. Способ хирургического лечения и профилактики рецидива кровотечений при варикозном расширении вен пищевода и кардиального отдела желудка. Патент на изобретение RU 2412657 C1, 27.02.2011. Заявка № 2009128518/14 от 23.07.2009.; Коробка ВЛ, Кострыкин МЮ, Шаповалов АМ. Лечение кровотечений из варикозно расширенных вен пищевода у больных из листа ожидания трансплантации печени. Вестник трансплантологии и искусственных органов. 2020; 22 (4): 58–64. doi:10.15825/1995-1191-2020-4-58-64.; De Franchis R; Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015; 63: 743–752. doi:10.1016/j.jhep.2015.05.022.; Варикозное расширение вен пищевода. Практические рекомендации Всемирной гастроэнтерологической организации. Available at: https://www.worldgastroenterology.org/UserFiles/file/guidelines/esophageal-varices-russian-2014.pdf.; Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003; 38 (1): 258–266. doi:10.1053/jhep.2003.50315.; Gantzel RH, Aagaard NK, Vilstrup H, Watson H, Grønbaek H, Jepsen P. Development and validation of the Cirrhotic Ascites Severity model-A patient-reported outcome-based model to predict 1-year mortality. Hepatol Commun. 2022 Nov; 6 (11): 3175–3185. doi:10.1002/hep4.2065.; Zhang M, Wang G, Zhao L, Wu Z, Zhang W, Zhang C. Second prophylaxis of variceal bleeding in cirrhotic patients with a high HVPG. Scand J Gastroenterol. 2016 Dec; 51 (12): 1502–1506. doi:10.1080/00365521.2016.1193218.; Liu J, Shi Q, Xiao S, Zhou C, Zhou B, Yuan F et al. Using transjugular intrahepatic portosystemic shunt as the firstline therapy in secondary prophylaxis of variceal hemorrhage. J Gastroenterol Hepatol. 2020 Feb; 35 (2): 278–283. doi:10.1111/jgh.14761.; Abraldes JG, Villanueva C, Bañares R, Aracil C, Catalina MV, Garci A-Pagán JC, Bosch J; Spanish Cooperative Group for Portal Hypertension and Variceal Bleeding. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol. 2008 Feb; 48 (2): 229–236. doi:10.1016/j.jhep.2007.10.008.; Sinagra E, Perricone G, D’Amico M, Tinè F, D’Amico G. Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis. Aliment Pharmacol Ther. 2014 Mar; 39 (6): 557–568. doi:10.1111/apt.12634.; Hofer BS, Simbrunner B, Bauer DJM, Paternostro R, Schwabl P, Scheiner B et al. Acute hemodynamic response to propranolol predicts bleeding and nonbleeding decompensation in patients with cirrhosis. Hepatol Commun. 2022 Sep; 6 (9): 2569–2580. doi:10.1002/hep4.2021.; La Mura V, Abraldes JG, Raffa S, Retto O, Berzigotti A, García-Pagán JC, Bosch J. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension. J Hepatol. 2009 Aug; 51 (2): 279–287. Epub 2009 May 24. PMID: 19501930. doi:10.1016/j.jhep.2009.04.015/.; Шаповалов АМ, Коробка ВЛ, Черкасов МФ. Способ хирургического лечения и профилактики кровотечений из варикозных вен пищевода и желудка. Медицинский вестник Юга России. 2015; (3): 112–115. doi:10.21886/2219-8075-20153-112-115.; https://journal.transpl.ru/vtio/article/view/1798

  3. 3
    Academic Journal

    Source: Russian Journal of Transplantology and Artificial Organs; Том 26, № 2 (2024); 16-27 ; Вестник трансплантологии и искусственных органов; Том 26, № 2 (2024); 16-27 ; 1995-1191

    File Description: application/pdf

    Relation: https://journal.transpl.ru/vtio/article/view/1766/1602; https://journal.transpl.ru/vtio/article/view/1766/1644; https://journal.transpl.ru/vtio/article/downloadSuppFile/1766/1541; https://journal.transpl.ru/vtio/article/downloadSuppFile/1766/1542; https://journal.transpl.ru/vtio/article/downloadSuppFile/1766/1543; https://journal.transpl.ru/vtio/article/downloadSuppFile/1766/1544; https://journal.transpl.ru/vtio/article/downloadSuppFile/1766/1545; https://journal.transpl.ru/vtio/article/downloadSuppFile/1766/1546; https://journal.transpl.ru/vtio/article/downloadSuppFile/1766/1547; https://journal.transpl.ru/vtio/article/downloadSuppFile/1766/1548; https://journal.transpl.ru/vtio/article/downloadSuppFile/1766/1549; https://journal.transpl.ru/vtio/article/downloadSuppFile/1766/1550; Liu L, Nie Y, Liu Q, Zhu X. A Practical Model for Predicting Esophageal Variceal Rebleeding in Patients with Hepatitis B-Associated Cirrhosis. Int J Clin Pract. 2023 Aug 3; 2023:9701841. DOI:10.1155/2023/9701841.; Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology 2017; 65: 310-335 DOI:10.1002/hep.28906.; Коробка В.Л., Пак Е.С., Шаповалов А.М., Кострыкин М.Ю., Ткачев А.В. Оценка четырехлетнего ведения листа ожидания трансплантации печени Ростовской области: перспективы снижения смертности в листе. Медицинский вестник Юга России. 2019;10(3):32-39. https://doi.org/10.21886/2219-8075-2019-10-3-32-39.; Kovalak M, Lake J, Mattek N, Eisen G, Lieberman D, Zaman A. Endoscopic screen-ing for varices in cirrhotic patients: data from a national endoscopic database. Gas-trointest Endosc. 2007 Jan;65(1):82-8. PMID: 17185084. DOI:10.1016/j.gie.2006.08.023.; North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med. 1988 Oct 13;319(15):983-9. DOI:10.1056/NEJM198810133191505.; Bosch J, García-Pagán JC. Prevention of variceal rebleeding. Lancet. 2003 Mar 15;361(9361):952-4. doi.org/10.1016/S0140-6736(03)12778-X.; De Franchis R; Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015; 63: 743-752. DOI:10.1016/j.jhep.2015.05.022; De Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VII Faculty. Baveno VII - Renewing consensus in portal hypertension. J Hepatol.2022;76(4):959-974. DOI:10.1016/j.jhep.2021.12.022; Garcia-Tsao G, Bosch J. Varices and Variceal Hemorrhage in Cirrhosis: A New View of an Old Problem. Clin Gastroenterol Hepatol 2015; 13: 2109-2117 DOI:10.1016/j.cgh.2015.07.012.; Lv Y, Qi X, He C, Wang Z, Yin Z, Niu J, Guo W, Bai W, Zhang H, Xie H, Yao L, Wang J, Li T, Wang Q, Chen H, Liu H, Wang E, Xia D, Luo B, Li X, Yuan J, Han N, Zhu Y, Xia J, Cai H, Yang Z, Wu K, Fan D, Han G; PVT-TIPS Study Group. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial. Gut. 2018 Dec;67(12):2156-2168. DOI:10.1136/gutjnl-2017-314634.; Abraldes JG, Villanueva C, Bañares R, Aracil C, Catalina MV, Garci A-Pagán JC, Bosch J; Spanish Cooperative Group for Portal Hypertension and Variceal Bleed-ing. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol. 2008 Feb;48(2):229-36. DOI:10.1016/j.jhep.2007.10.008.; Moitinho E, Escorsell A, Bandi JC, Salmerón JM, García-Pagán JC, Rodés J, Bosch J. Prognostic value of early measurements of portal pressure in acute variceal bleed-ing. Gastroenterology. 1999 Sep;117(3):626-31. PMID: 10464138. DOI:10.1016/s0016-5085(99)70455-5.; Ripoll C, Bañares R, Rincón D, Catalina MV, Lo Iacono O, Salcedo M, Clemente G, Núñez O, Matilla A, Molinero LM. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era. Hepatology. 2005 Oct;42(4):793-801. DOI:10.1002/hep.20871.; Sinagra E, Perricone G, D'Amico M, Tinè F, D'Amico G. Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis. Aliment Pharmacol Ther. 2014 Mar;39(6):557-68. DOI:10.1111/apt.12634.; Hofer BS, Simbrunner B, Bauer DJM, Paternostro R, Schwabl P, Scheiner B, et al. Acute hemodynamic response to propranolol predicts bleeding and nonbleeding de-compensation in patients with cirrhosis. Hepatol Commun. 2022 Sep;6(9):2569-2580. DOI:10.1002/hep4.2021.; La Mura V, Abraldes JG, Raffa S, Retto O, Berzigotti A, García-Pagán JC, Bosch J. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension. J Hepatol. 2009 Aug;51(2):279-87. Epub 2009 May 24. PMID: 19501930. DOI:10.1016/j.jhep.2009.04.015.; Коробка В.Л., Пасечников В.Д., Коробка Р.В., Пак Е.С., Шаповалов А.М. Использование эндоскопического лигирования варикозных узлов в комбинации с неселективными β-блокаторами, или самостоятельно, в профилактике кровотечений у больных с асцитом, включенных в лист ожидания трансплантации печени. Вестник трансплантологии и искусственных органов. 2022;24(3):42-50. DOI:10.15825/1995-1191-2022-3-42-50; Liu J, Shi Q, Xiao S, Zhou C, Zhou B, Yuan F, Zheng C, Lin S, Qian K, Feng G, Xiong B. Using transjugular intrahepatic portosystemic shunt as the first-line therapy in secondary prophylaxis of variceal hemorrhage. J Gastroenterol Hepatol. 2020 Feb;35(2):278-283. Epub 2019 Jul 18. PMID: 31222830; PMCID: PMC7027763. DOI:10.1111/jgh.14761.; Miao Z, Lu J, Yan J, Lu L, Ye B, Gu M. Comparison of Therapies for Secondary Prophylaxis of Esophageal Variceal Bleeding in Cirrhosis: A Network Meta-analysis of Randomized Controlled Trials. Clin Ther. 2020 Jul;42(7):1246-1275.e3. DOI:10.1111/jgh.14761.10.1016/j.clinthera.2020.04.014.; Holster IL, Tjwa ET, Moelker A, Wils A, Hansen BE, Vermeijden JR, Scholten P, van Hoek B, Nicolai JJ, Kuipers EJ, Pattynama PM, van Buuren HR. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β-blocker for prevention of variceal rebleeding. Hepatology. 2016 Feb;63(2):581-9. 10.1002/hep.28318. Epub 2015 Dec 28. PMID: 26517576. DOI:10.1111/jgh.14761.; Rössle M. TIPS: 25 years later. J Hepatol. 2013 Nov;59(5):1081-93. Epub 2013 Jun 25. PMID: 23811307. DOI:10.1016/j.jhep.2013.06.014.; Boregowda U, Umapathy C, Halim N, Desai M, Nanjappa A, Arekapudi S, Theethira T, Wong H, Roytman M, Saligram S. Update on the management of gastrointestinal varices. World J Gastrointest Pharmacol Ther. 2019 Jan 21;10(1):1-21. DOI:10.4292/wjgpt.v10.i1.1.; Korsic S, Stabuc B, Skok P, Popovic P. TIPS vs. endoscopic treatment for prevention of recurrent variceal bleeding: a long-term follow-up of 126 patients. Radiol Oncol. 2021 Jan 26;55(2):164-171. DOI:10.2478/raon-2021-0006.; Варикозное расширение вен пищевода. Практические рекомендации Всемирной Гастроэнтерологической Организации. Available from: https://www.worldgastroenterology.org/UserFiles/file/guidelines/esophageal-varices-russian-2014.pdf; Gantzel RH, Aagaard NK, Vilstrup H, Watson H, Grønbaek H, Jepsen P. Develop-ment and validation of the Cirrhotic Ascites Severity model-A patient-reported out-come-based model to predict 1-year mortality. Hepatol Commun. 2022 Nov;6(11):3175-3185. DOI:10.1002/hep4.2065.; Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, Angeli P, Porayko M, Moreau R, Garcia-Tsao G, Jimenez W, Planas R, Arroyo V. The management of as-cites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003; 38(1):258-66. DOI:10.1053/jhep.2003.50315; DeMers D, Wachs D. Physiology, Mean Arterial Pressure. [Updated 2023 Apr 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538226.; Хубутия М.Ш., Восканян С.Э., Сюткин В.Е., Чуланов В.П., Новрузбеков М.С., Пасечников В.Д., Коробка В.Л., Руммо О.О., Бессонова Е.Н., Багненко С.Ф., Абдулганиева Д.И. Рекомендации по профилактике и лечению инфекций вирусами гепатита В и С у больных, находящихся в Листе ожидания трансплантации печени, и реципиентов печени. Трансплантология. 2020;1 2(3):231-244. DOI:10.23873/2074-0506-2020-12-3-231-244.; Boike JR, Thomburg BG, Asrani SK, Fallon MB, Fortune BE, Izzy MJ, et al. North American Practice-Based Recommendations for Transjugular Intrahepatic Portosys-temic Shunts in Portal Hypertension. Clin Gastroenterol Hepatol. 2022;20(8):1636-1662.e36. PMID: 34274511 DOI:10.1016/j.cgh.2021.07.018; Büttner L, Aigner A, Pick L, Brittinger J, Stelb CJ, Böning G, Steitparth F. 25 years of experience with transjugular intrahepatic portosystemic shunt (TIPS): changes in patient selection and procedural aspects. Insights Imaging. 2022;13(1):73. PMID: 35416547. DOI:10.1186/s13244-022-01216-5.; Zhou Y, Zhang W, Zhang Z, Luo J, Gu J, Liu Q, Ma J, Yan Z, Chen S, Wang J. PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks. Eur J Gastroenterol Hepatol. 2020 Sep;32(9):1235-1243. PMID: 32744824; PMCID: PMC7423526. DOI:10.1097/MEG.0000000000001686.; Sauerbruch T, Mengel M, Dollinger M, Zipprich A, Rössle M, Panther E, Wiest R, Caca K, Hoffmeister A, Lutz H, Schoo R, Lorenzen H, Trebicka J, Appenrodt B, Schepke M, Fimmers R; German Study Group for Prophylaxis of Variceal Rebleed-ing. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy. Gastroenterology. 2015 Sep;149(3):660-8.e1. Epub 2015 May 16. PMID: 25989386. DOI:10.1053/j.gastro.2015.05.011.; Zhang M, Wang G, Zhao L, Wu Z, Zhang W, Zhang C. Second prophylaxis of vari-ceal bleeding in cirrhotic patients with a high HVPG. Scand J Gastroenterol. 2016 Dec;51(12):1502-1506. Epub 2016 Jul 5. PMID: 27379704. DOI:10.1080/00365521.2016.1193218.; Ardevol A, Alvarado-Tapias E, Garcia-Guix M, Brujats A, Gonzalez L, Hernández-Gea V, Aracil C, Pavel O, Cuyas B, Graupera I, Colomo A, Poca M, Torras X, Con-cepción M, Villanueva C. Early rebleeding increases mortality of variecal bleeders on secondary prophylaxis with β-blockers and ligation. Dig Liver Dis. 2020 Sep;52(9):1017-1025 Epub 2020 Jul 8. PMID: 32653417. DOI:10.1016/j.dld.2020.06.005.; Irisawa A, Saito A, Obara K, Shibukawa G, Takagi T, Shishido H, Sakamoto H, Sato Y, Kasukawa R. Endoscopic recurrence of esophageal varices is associated with the specific EUS abnormalities: severe periesophageal collateral veins and large perfo-rating veins. Gastrointest Endosc. 2001 Jan;53(1):77-84. PMID: 11154493. DOI:10.1067/mge.2001.108479.; Monescillo A, Martínez-Lagares F, Ruiz-del-Arbol L, Sierra A, Guevara C, Jiménez E, Marrero JM, Buceta E, Sánchez J, Castellot A, Peñate M, Cruz A, Peña E. Influ-ence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology. 2004 Oct;40(4):793-801. PMID: 15382120. DOI:10.1002/hep.20386.; https://journal.transpl.ru/vtio/article/view/1766

  4. 4
    Academic Journal

    Source: Russian Journal of Transplantology and Artificial Organs; Том 26, № 3 (2024); 32-42 ; Вестник трансплантологии и искусственных органов; Том 26, № 3 (2024); 32-42 ; 1995-1191

    File Description: application/pdf

    Relation: https://journal.transpl.ru/vtio/article/view/1800/1663; https://journal.transpl.ru/vtio/article/downloadSuppFile/1800/1633; https://journal.transpl.ru/vtio/article/downloadSuppFile/1800/1634; https://journal.transpl.ru/vtio/article/downloadSuppFile/1800/1635; https://journal.transpl.ru/vtio/article/downloadSuppFile/1800/1636; https://journal.transpl.ru/vtio/article/downloadSuppFile/1800/1637; https://journal.transpl.ru/vtio/article/downloadSuppFile/1800/1646; Liu L, Nie Y, Liu Q, Zhu X. A Practical Model for Predicting Esophageal Variceal Rebleeding in Patients with Hepatitis B-Associated Cirrhosis. Int J Clin Pract. 2023 Aug 3; 2023: 9701841. doi:10.1155/2023/9701841.; Garcia-Tsao G, Bosch J. Varices and Variceal Hemorrhage in Cirrhosis: A New View of an Old Problem. Clin Gastroenterol Hepatol. 2015; 13: 2109–2117. doi:10.1016/j.cgh.2015.07.012.; Asghar S, Mustafa J, Rehman HU, Farooq MK, Waheed MU, Shahid S. Predictors Of Re-Bleeding After Oesophageal Variceal Banding In Cirrhotic Patients At 4 Weeks. J Ayub Med Coll Abbottabad. 2023 Feb-Mar; 35 (1): 99–103. PMID: 36849386.; Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017; 65: 310–335. doi:10.1002/hep.28906.; Lv Y, Qi X, He C, Wang Z, Yin Z, Niu J et al. PVT-TIPS Study Group. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial. Gut. 2018 Dec; 67 (12): 2156–2168. doi:10.1136/gutjnl-2017-314634.; Islam M. What is the difference between predictor and risk factor in Epidemiological Study? Retrieved from: https://www.researchgate.net/post/What-is-the-difference-between-predictor-and-risk-factor-in-Epidemiological-Study/582199ab96b7e45bff5c4489/citation/download.; Moitinho E, Escorsell A, Bandi JC, Salmerón JM, García-Pagán JC, Rodés J, Bosch J. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology. 1999 Sep; 117 (3): 626–631. doi:10.1016/s0016-5085(99)70455-5.; Abraldes JG, Villanueva C, Bañares R, Aracil C, Catalina MV, Garci A-Pagán JC, Bosch J. Spanish Cooperative Group for Portal Hypertension and Variceal Bleeding. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol. 2008 Feb; 48 (2): 229–236. doi:10.1016/j.jhep.2007.10.008.; Ripoll C, Bañares R, Rincón D, Catalina MV, Lo Iacono O, Salcedo M et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era. Hepatology. 2005 Oct; 42 (4): 793–801. doi:10.1002/hep.20871.; Ardevol A, Alvarado-Tapias E, Garcia-Guix M, Brujats A, Gonzalez L, Hernández-Gea V et al. Early rebleeding increases mortality of variceal bleeders on secondary prophylaxis with β-blockers and ligation. Dig Liver Dis. 2020 Sep; 52 (9): 1017–1025. doi:10.1016/j.dld.2020.06.005.; De Franchis R. Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015; 63: 743–752. doi:10.1016/j.jhep.2015.05.022.; Варикозное расширение вен пищевода. Практические рекомендации Всемирной гастроэнтерологической организации. Available from: https://www.worldgastroenterology.org/UserFiles/file/guidelines/esophageal-varices-russian-2014.pdf.; Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003; 38 (1): 258–266. doi:10.1053/jhep.2003.50315.; Gantzel RH, Aagaard NK, Vilstrup H, Watson H, Grønbaek H, Jepsen P. Development and validation of the Cirrhotic Ascites Severity model-A patient-reported outcome-based model to predict 1-year mortality. Hepatol Commun. 2022 Nov; 6 (11): 3175–3185. doi:10.1002/hep4.2065.; Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014; 60 (2): 715–735. doi:10.1002/hep.27210.; DeMers D, Wachs D. Physiology, Mean Arterial Pressure. [Updated 2023 Apr 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538226.; Хубутия МШ, Восканян СЭ, Сюткин ВЕ, Чуланов ВП, Новрузбеков МС, Пасечников ВД и др. Рекомендации по профилактике и лечению инфекций вирусами гепатита В и С у больных, находящихся в листе ожидания трансплантации печени, и реципиентов печени. Трансплантология. 2020; 12 (3): 231–244. doi:10.23873/2074-0506-2020-12-3-231-244.; De Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VII Faculty. Baveno VII – Renewing consensus in portal hypertension. J Hepatol. 2022; 76 (4): 959–974. doi:10.1016/j.jhep.2021.12.022.; Hosmer DW Jr, Lemeshow S, May S. Applied Survival Analysis: Regression Modeling of Time-to-Event Data, Second Edition. New York: John Wiley & Sons, 2008; 416. doi:10.1002/9780470258019.fmatter.; Шарашова ЕЕ, Холматова КК, Горбатова МА, Гржибовский АМ. Применение регрессии Кокса в здравоохранении с использованием пакета статистических программ SPSS. Наука и здравоохранение. 2017; (6): 5–27.; Sinagra E, Perricone G, D’Amico M, Tinè F, D’Amico G. Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis. Aliment Pharmacol Ther. 2014 Mar; 39 (6): 557–568. doi:10.1111/apt.12634.; Hofer BS, Simbrunner B, Bauer DJM, Paternostro R, Schwabl P, Scheiner B et al. Acute hemodynamic response to propranolol predicts bleeding and nonbleeding decompensation in patients with cirrhosis. Hepatol Commun. 2022 Sep; 6 (9): 2569–2580. doi:10.1002/hep4.2021.; Коробка ВЛ, Пасечников ВД, Коробка РВ, Пак ЕС, Шаповалов АМ. Использование эндоскопического лигирования варикозных узлов в комбинации с неселективными β-блокаторами или самостоятельно в профилактике кровотечений у больных с асцитом, включенных в лист ожидания трансплантации печени. Вестник трансплантологии и искусственных органов. 2022; 24 (3): 42–50. doi:10.15825/1995-1191-2022-3-42-50.; Hunter SS, Hamdy S. Predictors of early re-bleeding and mortality after acute variceal haemorrhage. Arab J Gastroenterol. 2013 Jun; 14 (2): 63–67. doi:10.1016/j.ajg.2013.05.001.; Yaru H, Mei Z, Kaixin L, Ruyue C, Mingshu L. Predictive factors for re-bleeding of esophageal varices in hospitalized patients. Cell Mol Biol (Noisy-le-grand). 2022 Feb 28; 68 (2): 183–188. doi:10.14715/cmb/2022.68.2.26.; Pfisterer N, Dexheimer C, Fuchs EM, Bucsics T, Schwabl P, Mandorfer M et al. Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding. Aliment Pharmacol Ther. 2018 Apr; 47 (7): 966–979. doi:10.1111/apt.14485.; Teng D, Zuo H, Liu L, Dong J, Ding L. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment. Virol J. 2018 Oct 1; 15 (1): 151. doi:10.1186/s12985-018-1067-7.; Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R et al. Portal Hypertension Collaborative Group. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007 Aug; 133 (2): 481– 488. doi:10.1053/j.gastro.2007.05.024.; Irisawa A, Saito A, Obara K, Shibukawa G, Takagi T, Shishido H et al. Endoscopic recurrence of esophageal varices is associated with the specific EUS abnormalities: severe periesophageal collateral veins and large perforating veins. Gastrointest Endosc. 2001 Jan; 53 (1): 77–84. doi:10.1067/mge.2001.108479.; Zhang YH, Hu B. Future directions of noninvasive prediction of esophageal variceal bleeding: No worry about the present computed tomography inefficiency. World J Gastrointest Endosc. 2024 Mar 16; 16 (3): 108–111. doi:10.4253/wjge.v16.i3.108.; Martino A, Amitrano L, Guardascione M, Di Serafino M, Bennato R, Martino R et al. The role of computed tomography for the prediction of esophageal variceal bleeding: Current status and future perspectives. World J Gastrointest Endosc. 2023 Dec 16; 15 (12): 681–689. doi:10.4253/wjge.v15.i12.681.; Merkel C, Montagnese S. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as guidance for prophylaxis and treatment of bleeding and re-bleeding? Yes! Eur J Intern Med. 2011 Feb; 22 (1): 1–4. doi:10.1016/j.ejim.2010.08.009.; La Mura V, Abraldes JG, Raffa S, Retto O, Berzigotti A, García-Pagán JC, Bosch J. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension. J Hepatol. 2009 Aug; 51 (2): 279–287. Epub 2009 May 24. doi:10.1016/j.jhep.2009.04.015.; Zhao JR, Wang GC, Hu JH, Zhang CQ. Risk factors for early rebleeding and mortality in acute variceal hemorrhage. World J Gastroenterol. 2014 Dec 21; 20 (47): 17941–17948. doi:10.3748/wjg.v20.i47.17941.; Wu L, Fang QQ, Huang XQ, Xue CY, Rao CY, Luo JJ et al. Risk factors associated with failure of endoscopic combined treatment to prevent varices rebleeding in patients with liver cirrhosis. Expert Rev Gastroenterol Hepatol. 2023 Mar; 17 (3): 301–308. doi:10.1080/17474124.2023.2181787.; https://journal.transpl.ru/vtio/article/view/1800

  5. 5
    Academic Journal

    Source: Хірургія дитячого віку, Vol 0, Iss 2(67), Pp 29-35 (2020)
    PAEDIATRIC SURGERY. UKRAINE; № 2(67) (2020): Paediatric Surgery. Ukraine; 29-35
    ХИРУРГИЯ ДЕТСКОГО ВОЗРАСТА; № 2(67) (2020): Хирургия детского возраста; 29-35
    Хірургія дитячого віку; № 2(67) (2020): Хірургія дитячого віку; 29-35

    File Description: application/pdf

  6. 6
    Academic Journal

    Source: Transplantologiya. The Russian Journal of Transplantation; Том 15, № 2 (2023); 158-167 ; Трансплантология; Том 15, № 2 (2023); 158-167 ; 2542-0909 ; 2074-0506

    File Description: application/pdf

    Relation: https://www.jtransplantologiya.ru/jour/article/view/770/774; https://www.jtransplantologiya.ru/jour/article/view/770/796; De Franchis R, Bosch J, GarciaTsao G, Reiberger T, Ripoll C; Baveno VII Faculty. Baveno VII – Renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959–974. PMID: 35120736 https://doi.org/10.1016/j.jhep.2021.12.022; D'Amico G, Bernardi M, Angeli P. Towards a new definition of decompensated cirrhosis. J Hepatol. 2022;76(1):202–207. PMID: 34157322 https://doi.org/10.1016/j.jhep.2021.06.018; International report on organ donation and transplantation activities. Executive summary. 2018. October, 2020. Available at: https://www.transplant-observatory.org/wp-content/uploads/2020/10/glorep2018-2.pdf [Accessed March 30, 2023].; Toniutto P, Zanetto A, Ferrarese A, Burra P. Current challenges and future directions for liver transplantation. Liver Int. 2017;37(3):317–327. PMID: 27634369 https://doi.org/10.1111/liv.13255; Russo FP, Izzy M, Rammohan A, Kirchner VA, Di Maira T, Belli LS, et al. Global impact of the first wave of COVID-19 on liver transplant centers: a multi-society survey (EASL-ESOT/ELITA-ILTS). J Hepatol. 2022;76(2):364–370. PMID: 34653592 https://doi.org/10.1016/j.jhep.2021.09.041; Готье С.В., Хомяков С.М. Донорство и трансплантация органов в Российской Федерации в 2021 году. XIV сообщение регистра Российского трансплантологического общества. Вестник трансплантологии и искусственных органов. 2022;24(3):8–31. https://doi.org/10.15825/1995-1191-2022-3-8-31; Коробка В.Л., Пасечников В.Д., Коробка Р.В., Пак Е.С., Шаповалов А.М. Использование эндоскопического лигирования варикозных узлов в комбинации с неселективными β-блокаторами, или самостоятельно, в профилактике кровотечений у больных с асцитом, включенных в лист ожидания трансплантации печени. Вестник трансплантологии и искусственных органов. 2022;24(3):42–50. https://doi.org/10.15825/1995-1191-2022-3-42-50; De Franchis R, Baveno VI Faculty. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743–752. PMID: 26047908 https://doi.org/10.1016/j.jhep.2015.05.022; Esophageal Varices. World Gastroenterology Organisation Global Guidelines. January 2014. World Gastroenterology Organisation; 2013. Available at: https://www.worldgastroenterology.org/guidelines/esophageal-varices/esophagealvarices-english [Accessed March 30, 2023].; Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, et al. The management of ascites in cirrhosis: report on the consensus conference of the international Ascites club. Hepatology. 2003;38(1):258–266. PMID: 12830009 https://doi.org/10.1053/jhep.2003.50315; Leise MD, Kim WR, Kremers WK, Larson JJ, Larson JJ, Benson JT, et al. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation. Gastroenterology. 2011;140(7):1952–1960. PMID: 21334338 https://doi.org/10.1053/j.gastro.2011.02.017; Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg. 1964;1:1–85. PMID: 4950264; Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646–649. PMID: 4541913 https://doi.org/10.1002/bjs.1800600817; Garcia-Tsao G, Sanyal AJ, Grace ND, Carey WD. The Practice Guidelines Committee of the American Association of the Study of Liver Diseases, The Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology (Baltimore, Md.). 2007;46(3):922–938. PMID: 17879356 https://doi.org/10.1002/hep.21907; Carrion AF, Martin P. Keeping patients with end-stage liver disease alive while awaiting transplant: management of complications of portal hypertension. Clin Liver Dis. 2021;25(1):103–120. PMID: 33978573 https://doi.org/10.1016/j.cld.2020.08.007; Kovalak M, Lake J, Mattek N, Eisen G, Lieberman D, Zaman A. Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database. Gastrointest Endosc. 2007;65(1):82-88. PMID: 17185084 https://doi.org/10.1016/j.gie.2006.08.023; Vadera S, Yong CWK, Gluud LL, Morgan MY. Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices. Cochrane Database Syst Rev. 2019;6(6):CD012673. PMID: 31220333 https://doi.org/10.1002/14651858; Roccarina D, Best LM, Freeman SC, Roberts D, Cooper NJ, Sutton AJ, et al. Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network metaanalysis. Cochrane Database Syst Rev. 2021;4(4):CD013121. PMID: 33822357 https://doi.org/10.1002/14651858.CD013121.pub2; https://www.jtransplantologiya.ru/jour/article/view/770

  7. 7
  8. 8
  9. 9
    Academic Journal

    Source: Russian Journal of Transplantology and Artificial Organs; Том 24, № 3 (2022); 42-50 ; Вестник трансплантологии и искусственных органов; Том 24, № 3 (2022); 42-50 ; 1995-1191

    File Description: application/pdf

    Relation: https://journal.transpl.ru/vtio/article/view/1514/1329; https://journal.transpl.ru/vtio/article/view/1514/1405; Lee J, Lee JG, Jung I, Joo DJ, Kim SI, Kim MS. Advisory Committee on Improving Liver Allocation. Development of a Korean Liver Allocation System using Model for End Stage Liver Disease Scores: A Nationwide, Multicenter study. Sci Rep. 2019 May 16; 9 (1): 7495. doi:10.1038/s41598-019-43965-2. PMID: 31097768. PMCID: PMC6522508.; Adam R, Karam V, Delvart V, O’Grady J, Mirza D, Klempnauer J et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). Journal of Hepatology. 2012; 57 (3): 675–688.; Merion RM. Current status and future of liver transplantation. Seminars in Liver Disease. 2010; 30 (4): 411–421.; Organ Donation and Transplantation Activities. Executive Summary. 2018. International Report On www.transplant-observatory.org. October, 2020, 34 стр.; Garcia-Tsao G, Sanyal AJ, Grace ND, Carey WD. The Practice Guidelines Committee of the American Association of the Study of Liver Diseases, The Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology (Baltimore, Md.). 2007; 46 (3): 922–938. doi:10.1002/hep.21907. MEDLINE: 17879356.; Cordon JP, Torres CF, Garcia AB, Rodriguez FG, Suarez de Parga JM. Endoscopic management of esophageal varices. World Journal of Gastrointestinal Endoscopy. 2012; 4 (7): 312–322. doi:10.4253/wjge.v4.i7.312. MEDLINE: 22816012.; Carrion AF, Martin P. Keeping Patients with End-Stage Liver Disease Alive While Awaiting Transplant: Management of Complications of Portal Hypertension. Clin Liver Dis. 2021 Feb; 25 (1): 103–120. doi:10.1016/j.cld.2020.08.007. Epub 2020 Oct 17. PMID: 33978573.; Chawla S, Katz A, Attar BM, Gupta A, Sandhu DS, Agarwal R. Platelet count/spleen diameter ratio to predict the presence of esophageal varices in patients with cirrhosis: a systematic review. European Journal of Gastroenterology & Hepatology. 2012; 24 (4): 431–436.; McCarty TR, Afinogenova Y, Njei B. Use of wireless capsule endoscopy for the diagnosis and grading of esophageal varices in patients with portal hypertension: a systematic review and meta-analysis. Journal of Clinical Gastroenterology. 2017; 51 (2): 174–182.; Cales P, Desmorat H, Vinel JP, Caucanas JP, Ravaud A, Gerin P et al. Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding. Gut. 1990; 31 (11): 1298–1302.; Merli M, Nicolini G, Angeloni S, Rinaldi V, de Santis A, Merkel C et al. Incidence and natural history of small esophageal varices in cirrhotic patients. Journal of Hepatology. 2003; 38 (3): 266–272.; D’Amico G, Pasta L, Morabito A, D’Amico M, Caltagirone M, Malizia G et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Alimentary Pharmacology & Therapeutics. 2014; 39 (10): 1180–1193.; Gluud LL, Krag A. Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults. Cochrane Database of Systematic Reviews. 2012; Issue 8: CD004544. doi:10.1002/14651858.CD004544.pub2.; Qi XS, Bao YX, Bai M, Xu WD, Dai JN, Guo Z. Nonselective betablockers in cirrhotic patients with no or small varices: a meta-analysis. World Journal of Gastroenterology. 2015; 21 (10): 3100–3108.; Ioannou GN, Doust J, Rockey DC. Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database of Systematic Reviews. 2003; Issue 1: CD002147. doi:10.1002/14651858.CD002147.; Gøtzsche PC, Hróbjartsson A. Somatostatin analogues for acute bleeding oesophageal varices. Cochrane Database of Systematic Reviews. 2008; Issue 3: CD000193. doi:10.1002/14651858.CD000193.pub3.; D’Amico G, Pagliaro L, Pietrosi G, Tarantino I. Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patients. Cochrane Database of Systematic Reviews. 2010; Issue 3: CD002233. doi:10.1002/14651858.CD002233.pub2.; Ríos CE, Seron P, Gisbert JP, Bonfill CX. Endoscopic injection of cyanoacrylate glue versus other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension. Cochrane Database of Systematic Reviews. 2015; Issue 5: CD010180. doi:10.1002/14651858.CD010180.pub2.; Liu CL, Wu CK, Shi HY, Tai WC, Liang CM, Yang SC et al. Medical expenses in treating acute esophageal variceal bleeding: A 15-year nationwide population-based cohort study. Medicine (Baltimore). 2016 Jul; 95 (28): e4215. doi:10.1097/MD.0000000000004215. PMID: 27428225. PMCID: PMC4956819.; Elsebaey MA, Elashry H, Elbedewy TA, Elhadidy AA, Esheba NE, Ezat S et al. Predictors of in-hospital mortality in a cohort of elderly Egyptian patients with acute upper gastrointestinal bleeding. Medicine (Baltimore). 2018 Apr; 97 (16): e0403. doi:10.1097/MD.0000000000010403. PMID: 29668596. PMCID: PMC5916675.; De Franchis R. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015; 63: 743–752. PMID: 26047908. doi:10.1016/j.jhep.2015.05.022.; Sersté T, Melot C, Francoz C, Durand F, Rautou PE, Valla D et al. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology. 2010; 52: 1017–1022. doi:10.1002/hep.23775.; Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017; 65: 310–335. PMID: 27786365. doi:10.1002/hep.28906.; Leithead JA, Rajoriya N, Tehami N, Hodson J, Gunson BK, Tripathi D, Ferguson JW. Non-selective β-blockers are associated with improved survival in patients with ascites listed for liver transplantation. Gut. 2015 Jul; 64 (7): 1111–1119. doi:10.1136/gutjnl-2013-306502. Epub 2014 Oct 3. PMID: 25281417.; Mookerjee RP, Pavesi M, Thomsen KL, Mehta G, Macnaughtan J, Bendtsen F et al. CANONIC Study Investigators of the EASL-CLIF Consortium. Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure. J Hepatol. 2016 Mar; 64 (3): 574–582. doi:10.1016/j.jhep.2015.10.018. Epub 2015 Oct 28. PMID: 26519600.; Leise MD, Kim WR, Kremers WK, Larson JJ, Larson JJ, Benson JT, Therneau TM. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation. Gastroenterology. 2011; 140: 1952–1960. https://doi.org/10.1053/j.gastro.2011.02.017.; Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg. 1964; 1: 1–85. PMID: 4950264.; Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973 Aug; 60 (8): 646– 649. doi:10.1002/bjs.1800600817. PMID: 4541913.; Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003 Jul; 38 (1): 258–266. doi:10.1053/jhep.2003.50315. PMID: 12830009.; https://www.worldgastroenterology.org/guidelines/esophageal-varices/esophageal-varices-russian.; Angeli P, Gines P, Wong F, Bernardi M, Boyer TD, Gerbes A et al. International Club of Ascites. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut. 2015 Apr; 64 (4): 531–537. doi:10.1136/gutjnl-2014-308874. Epub 2015 Jan 28. PMID: 25631669.; D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006 Jan; 44 (1): 217–231. doi:10.1016/j.jhep.2005.10.013. Epub 2005 Nov 9. PMID: 16298014.; De Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VII – Renewing consensus in portal hypertension. J Hepatol. 2022 Apr; 76 (4): 959–974. doi:10.1016/j.jhep.2021.12.022. Epub 2021 Dec 30. Erratum in: J Hepatol. 2022 Jul; 77 (1): 271. Epub 2022 Apr 14. PMID: 35120736.; Pfisterer N, Dexheimer C, Fuchs EM, Bucsics T, Schwabl P, Mandorfer M et al. Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding. Aliment Pharmacol Ther. 2018 Apr; 47 (7): 966–979. doi:10.1111/apt.14485. Epub 2018 Feb 1. PMID: 29388229.; EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018 Aug; 69 (2): 406–460. doi:10.1016/j.jhep.2018.03.024. Epub 2018 Apr 10. Erratum in: J Hepatol. 2018 Nov; 69 (5): 1207. PMID: 29653741.; Téllez L, Albillos A. Non-selective beta-blockers in patients with ascites: The complex interplay among the liver, kidney and heart. Liver Int. 2022 Apr; 42 (4): 749– 761. doi:10.1111/liv.15166. Epub 2022 Feb 11. PMID: 35051310.; Angeli P, Garcia-Tsao G, Nadim MK, Parikh CR. News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document. J Hepatol. 2019 Oct; 71 (4): 811–822. doi:10.1016/j.jhep.2019.07.002. Epub 2019 Jul 11. PMID: 31302175.; Bernardi M, Moreau R, Angeli P, Schnabl B, Arroyo V. Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. J Hepatol. 2015 Nov; 63 (5): 1272–1284. doi:10.1016/j.jhep.2015.07.004. Epub 2015 Jul 17. PMID: 26192220.; Tergast TL, Kimmann M, Laser H, Gerbel S, Manns MP, Cornberg M, Maasoumy B. Systemic arterial blood pressure determines the therapeutic window of non-selective beta blockers in decompensated cirrhosis. Aliment Pharmacol Ther. 2019 Sep; 50 (6): 696–706. doi:10.1111/apt.15439. Epub 2019 Aug 2. PMID: 31373713.; Ferrarese A, Tikhonoff V, Casiglia E, Angeli P, Fasolato S, Faggian D et al. Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites. Gastroenterol Res Pract. 2018 May 9; 2018: 4098210. doi:10.1155/2018/4098210. PMID: 29861720. PMCID: PMC5971311.; Kalambokis GN, Christodoulou D, Baltayiannis G, Christou L. Propranolol use beyond 6 months increases mortality in patients with Child–Pugh C cirrhosis and ascites. Hepatology. 2016 Nov; 64 (5): 1806–1808. doi:10.1002/hep.28575. Epub 2016 Jun 1. PMID: 27016449.; Kim SG, Larson JJ, Lee JS, Therneau TM, Kim WR. Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates. Liver Transpl. 2017 Jun; 23 (6): 733–740. doi:10.1002/lt.24744. PMID: 28187503. PMCID: PMC5449204.; Yoo JJ, Kim SG, Kim YS, Lee B, Jeong SW, Jang JY et al. Propranolol plus endoscopic ligation for variceal bleeding in patients with significant ascites: Propensity score matching analysis. Medicine (Baltimore). 2020 Jan; 99 (5): e18913. doi:10.1097/MD.0000000000018913. PMID: 32000397. PMCID: PMC7004788.; https://journal.transpl.ru/vtio/article/view/1514

  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
    Academic Journal

    Source: Transplantologiya. The Russian Journal of Transplantation; № 3-4 (2010); 5-9 ; Трансплантология; № 3-4 (2010); 5-9 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2010-0-3-4

    File Description: application/pdf

    Relation: https://www.jtransplantologiya.ru/jour/article/view/286/349; Успанова Г. Гастродуоденальные язвы при портальной гипертензии. Дис. канд. мед. наук. Великий Новгород, 2006; с. 112.; Ханевич М.Д., Хрупкин В.И., Жерлов Г.К. и др. Кровотечения из хронических гастродуоденальных язв у больных внутрипеченочной портальной гипертензией. Новосибирск: Наука, 2003; с. 198.; Андрейцева О.И. Возможности ортотопической трансплантации печени у больных с терминальными поражениями печени. Consilium Medicum 2004;6(6).; Соколова О.В. Диагностика и лечение начальной стадии портальной гипертензии у больных хроническими диффузными прогрессирующими заболеваниями печени. Автореф. дис. … канд. мед. наук. М.; Борисов А.Е., Кащенко В.А., Васюкова Е.Л. и др. Эндоскопическая склеротерапия и лигирование варикозно расширенных вен пищевода и кардии. Хирургия 2002;8:36–8.; Ерамишанцев А.К. Эволюция хирургического лечения кровотечений из варикозно расширенных вен пищевода и желудка. 50 лекций по хирургии. Под ред. В.С. Савельева. М.: Триада-Х, 2004; с. 409–501.; Ерамишанцев А.К., Киценко Е.А., Шерцингер А.Г. и др. Кровотечение из варикозно расширенных вен пищевода и желудка: диагностика, лечебная тактика. Анналы хирургической гепатологии 2006;11(2):105–10.; Кошкин А.Б. Патогенез кровотечения из варикозно расширенных вен пищевода и желудка: обзор. Клиническая хирургия 1992;11:53–6.; Albillos A., Garsia-Pagan J.C., Ibbora I. et al. Propranolol plus prazozin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hyperten-sion. Gastroenterol 1998;115:116–23.; Пациора М.Д., Шерцингер А.Г., Киценко Е.А. Факторы риска возникновения кровотечений из варикозно-расширенных вен пищевода и желудка у больных портальной гипертензией. Клиническая медицина 1984:23–6.; Шерцингер А.Г. Патогенез, диагностика, профилактика, лечение кровотечений из варикозных вен пищевода и желудка у больных с портальной гипертензией. Автореф. дис. … д-ра мед. наук. М., 1986.; Яковенко А.В., Яковенко Э.П. Цирроз печени: вопросы терапии. Consilium Medicum 2006;8(7):14.; Auroux J., Lamarque D., Roudot-Thoraval F. et al. Gastroduodenal ulcer and erosions are related to portal hypertensive gastropathy and recent alcohol intake in cirrhotic patients. Dig Dis Sci 2003;48:6:1118–23.; Perez-Ayuso R.M., Valderrama S., Espinoza M. еt al. Endoscopic band ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhotic patient with high risk esophageal varices. Ann Hepatol 2010:15–22.; Кызымов И.Л. Эзофагогастродуоденальные кровотечения у больных портальной гипертензией. Хирургия 2007;(9):42–8.; Bohnacker S., Sriram P.V., Soehendra N. The role of endoscopic therapy in the treatment of bleeding varices. Baillieres Best Pract Res Clin Gastroenterol 2000:477–99.; Petrasch F., Grothaus J., Mossner J. et al. Differences in bleeding behavior after endoscopic band ligation: a retrospective analysis. BMC Gastroenterol 2010;Jan 15,10:5.; Кабанов М.В. Эндоскопическое лигирование варикозных вен пищевода у больных с портальной гипертензией. Дис. … канд. мед. наук. М., 2004; с. 103.; Шерцингер А.Г., Ерамишанцев А.К., Лебедев В.М. К вопросу о диагностике и консервативном лечении кровотечений из варикозно расширенных вен пищевода. Российский журнал гастроэнтерологии и гепатологии 1995;5(2).; Suzuki H., Ishii H. Peptic ulcer disease complicated with liver cirrhosis. Nippon Rinsho 2004;62(3):532–40.; Kamalaporn P., Sobhonslidsuk A., Jatchavala J. et al. Factors predisposing to peptic ulcer disease in asymptomatic cirrhotic patients. Aliment Pharmacol Ther 2005;21(12):1459–65.; Castro-Fernandez M., Sanchez-Munoz D., Galan-Jurado M.V. et al. Influence of nonsteroidal antiinflammatory drugs in gastrointestinal bleeding due to gastroduodenal ulcers or erosions in patients with liver cirrhosis. Gastroenterol Hepatol 2006;29:1:11–4.; Dore M.P., Mura D., Deledda S. et al. Active peptic ulcer disease in patients with hepatitis C virus-related cirrhosis: the role of Helicobacter pylori infection and portal hypertensive gastropathy. Can J Gastroenterol 2004;18:8:521–4.; Назыров Ф.Г., Акилов Х.А., Мансуров А.А. Тактика лечения кровотечения из варикозных вен гастроэзофагеального коллектора у больных с циррозом печени, осложненным портальной гипертензией. М.: Вестник хирургии, 2002; с. 81–3.; Оноприев В.И., Дурлештер В.М., Усова О.А. и др. Хирургическое лечение кровотечений из варикозно-расширенных вен пищевода и желудка. Хирургия 2005:38–42.; Киценко Е.А. Тактика ведения и медикаметозная терапия больных с портальной гипертензией. Росс журнал гастроэнтерол гепатол 1997; (5):14–8.; Распереза Д.В., Сишкова Е.А. Оценка эффективности эндоскопического лигирования комбинированного лечения (лигирование+склерозирование) в профилактике варикозных кровотечений при циррозе. Вестник Санкт-Петербургского университета 2008;11:144–5.; https://www.jtransplantologiya.ru/jour/article/view/286

  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20